EMJ GOLD: Pharma news, views and analysis

This week, we speak with Dr Jerome Kim, Director General, International Vaccine Institute, about vaccines. The conversation covers the nuances of the vaccine development process, the pharmaceutical industry's role in addressing vaccine hesitancy and refusal, and equitable distribution. He also shares his experience of working within the US military.

This week, we talk to Dirk Kosche, President, Established Markets, Astellas Pharma Europe Ltd, about turning innovation into value for patients, the role of the pharmaceutical industry in addressing health inequities, and his appreciation for the Japanese work culture. 

This week, we reflect on the highlights in pharma throughout July, covering the latest in COVID-19 developments, the most prestigious mergers and acquisitions, marketing standouts, and the latest in research and development.

This week, we speak with Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy. She explores the idea of co-designing clinical trials and treatment with patients, discusses the concept behind reverse mentoring, and reveals how the rules of improvisation help her when leading teams.

This week, we talk to Vanessa Pott, Director, Global Patient Insights and Advocacy, Merck KGaA, about her path into patient advocacy, the importance of recognising and supporting informal and family carers, and an MS awareness campaign that saw Merck partner with the gaming platform, Twitch.

This week, we speak with Alexey Cherchago, Head of Sales Excellence Europe, Sandoz, about leadership, how the role of the medical sales representative has evolved, and what the 'new normal' will look like within pharma's commercial teams.

This week, we reflect on the highlights in pharma throughout June, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.

This week, we talk to Denise Dewar, Digital Hub Director, Europe, Japan, and Canada, GSK. She discusses her transition from the whiskey industry to the pharmaceutical sector, the importance of viewing all customers first and foremost as people, and how digital transformation will improve patient outcomes in the future.

This week, we sit down with Ana Rita Ferreira, Region Europe Medical Director, Novartis, who discusses the challenges of delayed cancer care, her advocacy for women in STEM, and considers how the pharmaceutical industry can combat the challenge of misinformation as well as overcome bureaucracy.

This week, we speak to Lorena Kuri, Director of Clinical Trial Diversity Strategy, Bristol-Myers-Squibb, who discusses how to address underrepresentation in clinical trials, how teams can prioritise belonging, and how her experience as a board member of WOCIP has shaped her perspective and ambitions.

This week, we sit down with Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, who stresses the importance of onboarding diverse patient populations in clinical trials, explains what the challenges of patient retention are, and considers why virtual trials weren't embraced sooner.

This week, we reflect on the highlights in pharma throughout May. We will be covering the latest in COVID-19 and vaccine developments, the most prominent mergers and acquisitions, marketing highlights, and the latest in research and development.

This week, the conversation with Former England Rugby Coach and Former Director of Sport, Team GB, Sir Clive Woodward continues. Sir Clive explains the importance of teams having aligned values, the rules of teamship and how to apply them within organisations, and shares his top book recommendations.

This week, we sit down with Former England Rugby Coach and Former Director of Sport, Team GB, Sir Clive Woodward. Sir Clive shares with us the concept of Lombardi time and how winning teams should embrace it, as well as how marginal gains can have an overall gross impact on success.

This week, we speak to Florent Edouard, ‎Senior Vice President and Global Head of Commercial Excellence, Grünenthal Group, about his journey from finance to pharmaceuticals, the role of artificial intelligence in digital transformation, and wearing roller skates to work. 

This week, we reflect on the key happenings in pharma throughout April. We will be covering the latest in COVID-19 and vaccine developments, the most prestigious mergers and acquisitions, the latest in research and development, and marketing highlights.

This week, we sit down with Dr Emily Pegg, Head of Medical Affairs UK, Takeda Oncology, to consider how the pharmaceutical industry's relationship with healthcare professionals is evolving, discuss the future of the medical affairs function, and hear how she encourages and supports personal development within the teams she leads.

This week, we sit down with Timothy White, Vice President and Head of Global Digital Commercial, Teva Pharmaceuticals, to explore the subject of digital transformation. He discusses the 'four Es' of digital content, shares insight from the news and education platform NeurologyBytes, and reflects on his time working in the music industry.

This week, we are joined by Paul Simms, Chief Executive, Impatient Health and Pharma Provocateur, who shares his experience of the past year, the importance of overcoming red tape in pursuit of innovation, and his predictions for the pharmaceutical industry in 2021.

This week, we reflect on March in pharma and the key happenings from the month. We will be covering the latest in COVID-19 and vaccine developments, the most prestigious mergers and acquisitions, the latest in research and development, and more.

This week, we sit down with Claudia Martinez, Research Programme Manager, Access to Medicine Foundation, who explains the methodology behind the Access to Medicine Foundation's 2021 Index, why access to medicine is still a challenge for the pharmaceutical industry, and how companies can adapt their processes to reach to most vulnerable patient populations.

This week, we talk to Rob Jekielek, Managing Director, The Harris Poll, to explore evolving public perceptions of the pharmaceutical industry, considering how the progress made during COVID-19 can be sustained and what is needed to ensure their reputation improves even further.

This week, we sit down with Jose Maria (Chema) Guido Avila, Global Lead HCP Marketing, Sanofi, to hear his thoughts on the importance of combating misinformation, what metrics are most appropriate to measure the success of virtual events, and why Germany should be on everyone's travel list.

This week, we are joined by four esteemed guests from Ipsen's UK & Ireland team, including Asad Mohsin Ali, Managing Director, to discuss the fabric and value of high-performing teams, especially against a backdrop of the COVID-19 crisis.

This week, we reflect on February's month in the pharmaceutical industry, covering the latest in vaccine developments, the most promising mergers and acquisitions, and work at The European Commission which could encourage further international collaborations into 2021 and beyond.